The value of indirect immunofluorescence and solid phase techniques for ANCA detection. A report on the first phase of an international cooperative study on the standardization of ANCA assays. EEC/BCR Group for ANCA Assay Standardization. 1993

E C Hagen, and K Andrassy, and E Chernok, and M R Daha, and G Gaskin, and W Gross, and P Lesavre, and J Lüdemann, and C D Pusey, and N Rasmussen
Department of Nephrology, University Hospital Leiden, Netherlands.

This study describes the results of phase I of an international effort to develop and standardize assays for the detection of anti-neutrophil cytoplasmic antibodies (ANCA). 12 sera, four of which were selected for their potential to cause problems in the detection of various ANCA specificities, were analyzed in the standard indirect immunofluorescence (IIF) test and in ELISAs for ANCA routinely performed in the seven participating laboratories. The IIF methodology differed with respect to the dilution of the serum being screened and the concentration of the conjugate used. Results from sera with high ANCA titers were similar, although the quantitative values could not be compared. In sera containing rheumatoid factor and anti-nuclear antibodies (ANA), ANCA-unrelated staining patterns were observed. Six antigen preparations were used in ELISA for the detection of cANCA. In ELISA with purified proteinase-3 all three cANCA sera were positive, but not anti-myeloperoxidase (MPO) or anti-lactoferrin (LF) positive sera. The other assays were less sensitive or gave inconsistent results. Various preparations of purified MPO and LF used in ELISA were readily recognized by anti-MPO and anti-LF positive sera. From this study it can be concluded that the IIF test, although performed with different methods, shows comparable results using strongly positive sera. In general solid phase assays for cANCA detection are not well standardized and need improvement although the purified proteinase-3 ELISA is possibly an exception. MPO and LF can be used in ELISA procedures for the detection of pANCA-related antibodies.

UI MeSH Term Description Entries
D007391 International Cooperation The interaction of persons or groups of persons representing various nations in the pursuit of a common goal or interest. Foreign Aid,Treaties,Aid, Foreign,Cooperation, International,Treaty
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody
D019268 Antibodies, Antineutrophil Cytoplasmic Autoantibodies directed against cytoplasmic constituents of POLYMORPHONUCLEAR LEUKOCYTES and/or MONOCYTES. They are used as specific markers for GRANULOMATOSIS WITH POLYANGIITIS and other diseases, though their pathophysiological role is not clear. ANCA are routinely detected by indirect immunofluorescence with three different patterns: c-ANCA (cytoplasmic), p-ANCA (perinuclear), and atypical ANCA. ANCA,Anti-Neutrophil Cytoplasmic Autoantibodies,Anti-Neutrophil Cytoplasmic Autoantibody,Antineutrophil Cytoplasmic Antibodies,Neutrophil Cytoplasmic Autoantibodies,Neutrophil Cytoplasmic Autoantibody,c-ANCA,p-ANCA,Anti-Neutrophil Cytoplasmic Antibodies,Anti-Neutrophil Cytoplasmic Antibody,Antineutrophil Cytoplasmic Antibody,Anti Neutrophil Cytoplasmic Antibodies,Anti Neutrophil Cytoplasmic Antibody,Anti Neutrophil Cytoplasmic Autoantibodies,Anti Neutrophil Cytoplasmic Autoantibody,Antibody, Anti-Neutrophil Cytoplasmic,Antibody, Antineutrophil Cytoplasmic,Autoantibody, Anti-Neutrophil Cytoplasmic,Autoantibody, Neutrophil Cytoplasmic,Cytoplasmic Antibody, Anti-Neutrophil,Cytoplasmic Antibody, Antineutrophil,Cytoplasmic Autoantibody, Anti-Neutrophil,Cytoplasmic Autoantibody, Neutrophil,c ANCA,p ANCA

Related Publications

E C Hagen, and K Andrassy, and E Chernok, and M R Daha, and G Gaskin, and W Gross, and P Lesavre, and J Lüdemann, and C D Pusey, and N Rasmussen
June 2018, Autoimmunity reviews,
E C Hagen, and K Andrassy, and E Chernok, and M R Daha, and G Gaskin, and W Gross, and P Lesavre, and J Lüdemann, and C D Pusey, and N Rasmussen
October 2011, Autoimmunity reviews,
E C Hagen, and K Andrassy, and E Chernok, and M R Daha, and G Gaskin, and W Gross, and P Lesavre, and J Lüdemann, and C D Pusey, and N Rasmussen
June 2020, Annals of the rheumatic diseases,
E C Hagen, and K Andrassy, and E Chernok, and M R Daha, and G Gaskin, and W Gross, and P Lesavre, and J Lüdemann, and C D Pusey, and N Rasmussen
July 1995, Clinical and experimental immunology,
E C Hagen, and K Andrassy, and E Chernok, and M R Daha, and G Gaskin, and W Gross, and P Lesavre, and J Lüdemann, and C D Pusey, and N Rasmussen
January 1989, APMIS. Supplementum,
E C Hagen, and K Andrassy, and E Chernok, and M R Daha, and G Gaskin, and W Gross, and P Lesavre, and J Lüdemann, and C D Pusey, and N Rasmussen
January 1989, APMIS. Supplementum,
E C Hagen, and K Andrassy, and E Chernok, and M R Daha, and G Gaskin, and W Gross, and P Lesavre, and J Lüdemann, and C D Pusey, and N Rasmussen
January 1998, Journal of clinical laboratory analysis,
E C Hagen, and K Andrassy, and E Chernok, and M R Daha, and G Gaskin, and W Gross, and P Lesavre, and J Lüdemann, and C D Pusey, and N Rasmussen
January 1980, Allergie und Immunologie,
E C Hagen, and K Andrassy, and E Chernok, and M R Daha, and G Gaskin, and W Gross, and P Lesavre, and J Lüdemann, and C D Pusey, and N Rasmussen
November 2019, Autoimmunity reviews,
E C Hagen, and K Andrassy, and E Chernok, and M R Daha, and G Gaskin, and W Gross, and P Lesavre, and J Lüdemann, and C D Pusey, and N Rasmussen
May 1984, Acta virologica,
Copied contents to your clipboard!